GHK-Cu peptide TikTok claims: what the science actually supports

What did @everest_aesthetics actually say?

The creator said they use a "prescription only" GHK-Cu topical at "two milligrams per gram" and tagged someone who "does telehealth" and "can prescribe it to anybody in any state." That's the whole claim. No wild benefits stated, no disease cures promised. Just a product recommendation and a referral to a prescriber.

To be clear about what this video is: it's a direct response to DMs asking which GHK-Cu product they use. The creator isn't positioning themselves as a clinician. But the referral mechanic here, pointing followers toward a specific telehealth prescriber as a "plug," raises real regulatory questions worth addressing separately from the science.

Does the science back this up?

GHK-Cu (copper peptide GHK-Cu) has a legitimate research base, particularly in dermatology. The evidence is real but often overstated in wellness circles.

GHK-Cu is a naturally occurring copper-binding tripeptide. It was first isolated from human plasma by Pickart in 1973 and has since been studied for its effects on collagen synthesis, wound healing, and skin remodeling. A 2018 review by Pickart, Vasquez-Soltero, and Margolina published in Biomolecules summarized several decades of research showing GHK-Cu can stimulate collagen and glycosaminoglycan synthesis in fibroblasts and has antioxidant properties in vitro.

The problem is that most compelling data comes from in vitro or animal studies. Human clinical trials on topical GHK-Cu for cosmetic outcomes are limited in sample size and often industry-funded. A 2009 study by Leyden et al. in Journal of Cosmetic Dermatology showed some improvement in skin laxity and fine lines with topical application, but the trial was small. The science is promising, not proven. Anyone presenting GHK-Cu as a guaranteed skin transformer is outrunning the data.

What did they get wrong (or right)?

The creator deserves credit for not making extravagant claims. They didn't say it erases wrinkles, treats a disease, or reverses aging. That restraint is rarer than it should be in peptide content.

What's worth scrutinizing is the concentration. "Two milligrams per gram" equals 0.2%, which sits within the range used in published cosmetic studies. That part checks out. However, the framing that a telehealth provider "can prescribe it to anybody in any state" is where things get legally murky.

GHK-Cu is not FDA-approved as a drug. Compounded formulations exist in a regulatory gray zone under 503A pharmacy rules. Whether a telehealth prescriber can legally prescribe a compounded peptide topical across all 50 states depends heavily on state-specific pharmacy and prescribing laws, not just the prescriber's telehealth licensure. The blanket "any state" claim is almost certainly an oversimplification and could mislead followers into thinking there are no legal or regulatory barriers to access.

The casual referral to a specific prescriber as a "plug" also raises questions about whether this constitutes paid promotion or a referral arrangement, which would require FTC disclosure.

What should you actually know?

If you're interested in a topical GHK-Cu product, here's what actually matters for making an informed decision.

• GHK-Cu has real, peer-reviewed evidence for supporting skin fibroblast activity and collagen production, primarily from lab and animal research. Human data exists but is limited.
• Concentration matters. Products ranging from 0.1% to 1% appear in the literature. The 0.2% concentration mentioned in this video is within studied ranges.
• Prescription-compounded does not mean superior to over-the-counter. Compounded formulations bypass FDA review of safety and efficacy. That's not automatically bad, but it's not automatically better either.
• Telehealth prescribing of compounded peptides varies by state. A prescriber licensed in one state may not legally prescribe to patients in another, depending on reciprocity and state pharmacy board rules. "Any state" is a claim that warrants verification before you sign up.
• If you're pursuing any compounded peptide product, confirm the pharmacy has 503A accreditation and ask your prescriber about their specific state licensure before sharing personal health information.

Bottom line

This video is one of the more restrained GHK-Cu promotions you'll find on TikTok. The creator didn't oversell the peptide. But the referral infrastructure being promoted here, a specific telehealth prescriber as a cross-state "plug" for compounded peptides, deserves more scrutiny than a casual caption gets. The science on GHK-Cu is interesting. The regulatory picture around prescribing it is less tidy than this video implies.